Sean Murphy is a seasoned professional in the field of chemistry and drug development, currently serving as Sr. Director at Plexium since October 2023, where leadership is provided on a novel degrader program and oversight of the Computational Chemistry group. Previously, at Takeda from August 2022 to October 2023, Sean held the position of Director, managing a team of 12 focusing on CNS programs in narcolepsy, schizophrenia, and Alzheimer's. Prior to that, Sean was Associate Director at Takeda California, Inc., mentoring project leaders on schizophrenia, autism, and depression initiatives, and implementing cheminformatics tools. Experience also includes roles at Takeda San Diego, Inc., and Pfizer Pharmaceuticals, where significant contributions were made to projects in various therapeutic areas, including oncology and antibacterials. Sean earned a Ph.D. in Organic Chemistry from the University of Illinois Urbana-Champaign and a Bachelor's degree in Chemistry from the University of Wisconsin-Madison.
This person is not in any teams
This person is not in any offices